Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,945-1,956 of 4,306
Other study type icon
CompletedNCT00999895

A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Pátrai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Greece
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT00520923

A Study for people with Schizophrenia

This study is completed in Argentina, in Austria, in Croatia, .... It focuses on schizophrenia.

Multiple locations, including Banfield
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Argentina, Austria, Croatia, ...
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Drug study icon
TerminatedNCT01125358

A Study in Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Aichi
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 65 Years
Countries
Japan, South Korea, Taiwan
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT01077791

A Remediation Program of Social Cognition in Schizophrenia

This study was terminated in France. It is testing remediation Program of Social Cognition for schizophrenia.

In Le Chesnay
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 57 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Schizophrenia
Drug study icon
CompletedNCT00300846

Treatment of Aripiprazole for Schizophrenia

This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing treatment of Aripiprazole for Schizophrenia.

Multiple locations, including Graz
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00567203

Treatment Of Cognitive Deficits for schizophrenia

This study is completed in the United States. It is testing treatment Of Cognitive Deficits for schizophrenia.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Pfizer
Condition
Schizophrenia
Drug study icon
CompletedNCT01903837

ALKS 3831 in Adults With Schizophrenia

This study is completed in the United States, in Bulgaria, and in Czechia. It is testing ALKS 3831 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Bulgaria, Czechia
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02694328

ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)

This study is completed in the United States. It is testing ALKS 3831 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01493726

ALKS 9072 in Subjects With Chronic Stable Schizophrenia

This study is completed in the United States. It is testing ALKS 9072 for schizophrenia.

Multiple locations, including Atlanta
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00237939

Aripiprazole in the Management of people with Schizophrenia in the General Psychiatric Practices

This study is completed in France, in Belgium, in the Netherlands, .... It is testing aripiprazole for schizophrenia.

Multiple locations, including Antwerp
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, Belgium, Netherlands, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.